On June 27, Anthony Coletta, MD, MBA, president of Independence Blue Cross’s Facilitated Health Networks and executive vice president of Independence, joined a panel discussion at the National Comprehensive Cancer Network (NCCN) Policy Summit: Emerging Issues and Opportunities in Health Information Technology in Washington, D.C. Dr. Coletta and his fellow panelists addressed the state of health information technology (HIT) and its role in implementing the National Cancer Moonshot Initiative….
whole genome sequencing
Philadelphia, PA — Independence Blue Cross (Independence) announced today that it has entered into an agreement with NantHealth to cover next-generation whole genome sequencing for a variety of cancers. Independence will become the first major insurer to offer coverage for next-generation whole genome sequencing, which fully sequences thousands of genes in a single test, detecting DNA mutations that may serve as markers that inform decisions about optimal cancer therapy….
TOP